Zions Bancorporation, N.A. Repligen Corp Transaction History

Zions Bancorporation, N.A.

$1.58 Billion
Q4 2024

A detailed history of Zions Bancorporation, N.A. transactions in Repligen Corp stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 14,079 shares of RGEN stock, worth $1.69 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

14,079

Previous 9,453 48.94%

Holding current value

$1.69 Million

Previous $1.41 Million 44.1%

% of portfolio

0.13%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$123.41 - $160.92 $570,894 - $744,415	4,626 Added 48.94%	14,079 $2.03 Million
Q3 2024 Nov 06, 2024	BUY	$119.79 - $167.35 $192,622 - $269,098	1,608 Added 20.5%	9,453 $1.41 Million
Q2 2024 Aug 08, 2024	SELL	$120.0 - $182.95 $29,640 - $45,188	-247 Reduced 3.05%	7,845 $988,000
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $65,408 - $79,824	383 Added 4.97%	8,092 $1.49 Million
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $69,072 - $112,136	605 Added 8.52%	7,709 $1.39 Million
Q3 2023 Nov 07, 2023	BUY	$138.78 - $176.51 $93,398 - $118,791	673 Added 10.46%	7,104 $1.13 Million
Q2 2023 Jul 28, 2023	BUY	$138.42 - $180.31 $8,720 - $11,359	63 Added 0.99%	6,431 $909,000
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $93,173 - $119,652	604 Added 10.48%	6,368 $1.07 Million
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $146,827 - $199,386	904 Added 18.6%	5,764 $975,000
Q3 2022 Nov 08, 2022	SELL	$160.42 - $256.21 $962 - $1,537	-6 Reduced 0.12%	4,860 $909,000
Q2 2022 Aug 05, 2022	BUY	$140.68 - $188.02 $684,548 - $914,905	4,866 New	4,866 $790,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $24,178 - $38,694	-150 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $29,215 - $48,631	150 New	150 $43,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.67B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Repligen Corp Transaction History